Ose Pharma Sa Stock Total Debt
OSE Stock | EUR 5.56 0.04 0.71% |
OSE Pharma SA fundamentals help investors to digest information that contributes to OSE Pharma's financial success or failures. It also enables traders to predict the movement of OSE Stock. The fundamental analysis module provides a way to measure OSE Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OSE Pharma stock.
OSE |
OSE Pharma SA Company Total Debt Analysis
OSE Pharma's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current OSE Pharma Total Debt | 34.77 M |
Most of OSE Pharma's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OSE Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition |
Based on the latest financial disclosure, OSE Pharma SA has a Total Debt of 34.77 M. This is 98.74% lower than that of the Biotechnology sector and 89.3% lower than that of the Health Care industry. The total debt for all France stocks is 99.35% higher than that of the company.
OSE Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OSE Pharma's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OSE Pharma could also be used in its relative valuation, which is a method of valuing OSE Pharma by comparing valuation metrics of similar companies.OSE Pharma is currently under evaluation in total debt category among related companies.
OSE Fundamentals
Return On Equity | -0.15 | |||
Return On Asset | -0.0528 | |||
Profit Margin | (0.22) % | |||
Operating Margin | (0.25) % | |||
Current Valuation | 128.18 M | |||
Shares Outstanding | 18.44 M | |||
Shares Owned By Insiders | 39.03 % | |||
Shares Owned By Institutions | 1.81 % | |||
Price To Earning | 10.60 X | |||
Price To Book | 2.64 X | |||
Price To Sales | 3.69 X | |||
Revenue | 26.31 M | |||
Gross Profit | 26.31 M | |||
EBITDA | (13.72 M) | |||
Net Income | (16.85 M) | |||
Cash And Equivalents | 33.58 M | |||
Cash Per Share | 0.84 X | |||
Total Debt | 34.77 M | |||
Debt To Equity | 7.20 % | |||
Current Ratio | 2.54 X | |||
Book Value Per Share | 2.53 X | |||
Cash Flow From Operations | (9.92 M) | |||
Earnings Per Share | (0.41) X | |||
Target Price | 14.1 | |||
Number Of Employees | 60 | |||
Beta | 1.06 | |||
Market Capitalization | 104.49 M | |||
Total Asset | 101.88 M | |||
Retained Earnings | 25 M | |||
Working Capital | 22 M | |||
Current Asset | 30 M | |||
Current Liabilities | 8 M | |||
Z Score | 1.8 | |||
Net Asset | 101.88 M |
About OSE Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OSE Pharma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OSE Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OSE Pharma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OSE Pharma SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the OSE Pharma SA information on this page should be used as a complementary analysis to other OSE Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |